nodes	percent_of_prediction	percent_of_DWPC	metapath
Estramustine—ABCB1—Topotecan—cervical cancer	0.427	0.625	CbGbCtD
Estramustine—CYP3A4—Topotecan—cervical cancer	0.256	0.375	CbGbCtD
Estramustine—MAP1A—decidua—cervical cancer	0.0223	0.0732	CbGeAlD
Estramustine—MAP1A—uterus—cervical cancer	0.0195	0.064	CbGeAlD
Estramustine—MAP1A—female gonad—cervical cancer	0.016	0.0524	CbGeAlD
Estramustine—MAP1A—vagina—cervical cancer	0.0159	0.0521	CbGeAlD
Estramustine—MAP2—uterine cervix—cervical cancer	0.0133	0.0437	CbGeAlD
Estramustine—MAP2—decidua—cervical cancer	0.0127	0.0416	CbGeAlD
Estramustine—MAP2—endometrium—cervical cancer	0.012	0.0395	CbGeAlD
Estramustine—MAP2—mammalian vulva—cervical cancer	0.0116	0.0382	CbGeAlD
Estramustine—MAP1A—lymph node—cervical cancer	0.0103	0.0337	CbGeAlD
Estramustine—MAP2—female reproductive system—cervical cancer	0.00998	0.0327	CbGeAlD
Estramustine—MAP2—female gonad—cervical cancer	0.00908	0.0298	CbGeAlD
Estramustine—MAP2—vagina—cervical cancer	0.00902	0.0296	CbGeAlD
Estramustine—ESR2—epithelium—cervical cancer	0.0087	0.0285	CbGeAlD
Estramustine—ESR2—uterine cervix—cervical cancer	0.00863	0.0283	CbGeAlD
Estramustine—ESR2—renal system—cervical cancer	0.00807	0.0265	CbGeAlD
Estramustine—ESR2—endometrium—cervical cancer	0.0078	0.0256	CbGeAlD
Estramustine—ESR2—uterus—cervical cancer	0.00719	0.0236	CbGeAlD
Estramustine—ESR2—female reproductive system—cervical cancer	0.00647	0.0212	CbGeAlD
Estramustine—ESR1—epithelium—cervical cancer	0.00596	0.0195	CbGeAlD
Estramustine—ESR1—uterine cervix—cervical cancer	0.00591	0.0194	CbGeAlD
Estramustine—ESR2—female gonad—cervical cancer	0.00588	0.0193	CbGeAlD
Estramustine—ESR2—vagina—cervical cancer	0.00585	0.0192	CbGeAlD
Estramustine—MAP2—lymph node—cervical cancer	0.00584	0.0191	CbGeAlD
Estramustine—ESR1—decidua—cervical cancer	0.00563	0.0185	CbGeAlD
Estramustine—ESR1—renal system—cervical cancer	0.00553	0.0181	CbGeAlD
Estramustine—ESR1—endometrium—cervical cancer	0.00535	0.0175	CbGeAlD
Estramustine—ESR1—uterus—cervical cancer	0.00493	0.0161	CbGeAlD
Estramustine—ESR1—female reproductive system—cervical cancer	0.00443	0.0145	CbGeAlD
Estramustine—ESR1—female gonad—cervical cancer	0.00403	0.0132	CbGeAlD
Estramustine—ESR1—vagina—cervical cancer	0.004	0.0131	CbGeAlD
Estramustine—ESR2—lymph node—cervical cancer	0.00378	0.0124	CbGeAlD
Estramustine—CYP3A4—renal system—cervical cancer	0.00308	0.0101	CbGeAlD
Estramustine—ESR1—lymph node—cervical cancer	0.00259	0.00849	CbGeAlD
Estramustine—CYP3A4—female reproductive system—cervical cancer	0.00247	0.0081	CbGeAlD
Estramustine—ABCB1—epithelium—cervical cancer	0.00235	0.00772	CbGeAlD
Estramustine—ABCB1—uterine cervix—cervical cancer	0.00233	0.00765	CbGeAlD
Estramustine—ABCB1—decidua—cervical cancer	0.00222	0.00729	CbGeAlD
Estramustine—ABCB1—renal system—cervical cancer	0.00218	0.00716	CbGeAlD
Estramustine—ABCB1—endometrium—cervical cancer	0.00211	0.00692	CbGeAlD
Estramustine—ABCB1—mammalian vulva—cervical cancer	0.00204	0.0067	CbGeAlD
Estramustine—ABCB1—uterus—cervical cancer	0.00195	0.00638	CbGeAlD
Estramustine—ABCB1—female reproductive system—cervical cancer	0.00175	0.00573	CbGeAlD
Estramustine—ABCB1—female gonad—cervical cancer	0.00159	0.00522	CbGeAlD
Estramustine—ABCB1—vagina—cervical cancer	0.00158	0.00519	CbGeAlD
Estramustine—ESR2—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00121	0.0961	CbGpPWpGaD
Estramustine—ABCB1—lymph node—cervical cancer	0.00102	0.00335	CbGeAlD
Estramustine—ESR2—Nuclear Receptors—RARB—cervical cancer	0.000965	0.0766	CbGpPWpGaD
Estramustine—ESR2—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000763	0.0605	CbGpPWpGaD
Estramustine—MAP2—LKB1 signaling events—MTOR—cervical cancer	0.000697	0.0553	CbGpPWpGaD
Estramustine—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.000611	0.0484	CbGpPWpGaD
Estramustine—ESR1—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.000506	0.0401	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptors—RARB—cervical cancer	0.000487	0.0386	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000439	0.0348	CbGpPWpGaD
Estramustine—MAP2—LKB1 signaling events—TP53—cervical cancer	0.000411	0.0326	CbGpPWpGaD
Estramustine—ESR1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000385	0.0305	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—UBE3A—cervical cancer	0.000375	0.0297	CbGpPWpGaD
Estramustine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000281	0.0223	CbGpPWpGaD
Estramustine—ESR1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000273	0.0216	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000265	0.021	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000229	0.0181	CbGpPWpGaD
Estramustine—MAP2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00022	0.0175	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000195	0.0154	CbGpPWpGaD
Estramustine—ESR1—ATF-2 transcription factor network—HES1—cervical cancer	0.000186	0.0147	CbGpPWpGaD
Estramustine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000173	0.0138	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.000169	0.0134	CbGpPWpGaD
Estramustine—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000167	0.0133	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—TERT—cervical cancer	0.000145	0.0115	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—MTOR—cervical cancer	0.000135	0.0107	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000134	0.0106	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—RARB—cervical cancer	0.000132	0.0105	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.000105	0.00833	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	9.91e-05	0.00786	CbGpPWpGaD
Estramustine—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	9.42e-05	0.00747	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—MTOR—cervical cancer	9.39e-05	0.00745	CbGpPWpGaD
Estramustine—ESR1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	9.02e-05	0.00715	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CASP3—cervical cancer	8.81e-05	0.00699	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NOTCH2—cervical cancer	8.73e-05	0.00692	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—MTOR—cervical cancer	8.68e-05	0.00689	CbGpPWpGaD
Estramustine—ESR2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	8.5e-05	0.00674	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	8.2e-05	0.0065	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—CTNNB1—cervical cancer	8.13e-05	0.00645	CbGpPWpGaD
Estramustine—ESR1—LKB1 signaling events—TP53—cervical cancer	7.99e-05	0.00634	CbGpPWpGaD
Estramustine—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	7.88e-05	0.00625	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	7.5e-05	0.00595	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	7.23e-05	0.00573	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	7.08e-05	0.00561	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—FGFR3—cervical cancer	7.01e-05	0.00556	CbGpPWpGaD
Estramustine—ESR1—Leptin signaling pathway—STAT3—cervical cancer	6.71e-05	0.00532	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—RARB—cervical cancer	6.64e-05	0.00527	CbGpPWpGaD
Estramustine—ESR1—Regulation of Telomerase—EGFR—cervical cancer	6.59e-05	0.00523	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—RARB—cervical cancer	6.34e-05	0.00503	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	6.03e-05	0.00478	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	5.72e-05	0.00454	CbGpPWpGaD
Estramustine—ESR1—AP-1 transcription factor network—TP53—cervical cancer	5.41e-05	0.00429	CbGpPWpGaD
Estramustine—ESR2—Generic Transcription Pathway—NOTCH1—cervical cancer	5.4e-05	0.00429	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP8—cervical cancer	5.36e-05	0.00425	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	4.99e-05	0.00396	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	4.96e-05	0.00393	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—MTOR—cervical cancer	4.93e-05	0.00391	CbGpPWpGaD
Estramustine—ESR2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	4.81e-05	0.00381	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	4.56e-05	0.00362	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH2—cervical cancer	4.4e-05	0.00349	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	4.4e-05	0.00349	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH2—cervical cancer	4.2e-05	0.00333	CbGpPWpGaD
Estramustine—ABCB1—Allograft Rejection—CASP3—cervical cancer	4.05e-05	0.00321	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	3.78e-05	0.003	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	3.64e-05	0.00289	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	3.48e-05	0.00276	CbGpPWpGaD
Estramustine—ESR1—Signaling by ERBB4—EGFR—cervical cancer	3.47e-05	0.00275	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TAAR6—cervical cancer	3.32e-05	0.00263	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—RARB—cervical cancer	3.2e-05	0.00254	CbGpPWpGaD
Estramustine—ESR1—Integrated Breast Cancer Pathway—TP53—cervical cancer	2.92e-05	0.00232	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	2.89e-05	0.00229	CbGpPWpGaD
Estramustine—ESR1—Generic Transcription Pathway—NOTCH1—cervical cancer	2.72e-05	0.00216	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	2.64e-05	0.0021	CbGpPWpGaD
Estramustine—ESR2—Gene Expression—NOTCH1—cervical cancer	2.6e-05	0.00206	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—WNT2—cervical cancer	2.59e-05	0.00205	CbGpPWpGaD
Estramustine—ESR1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.42e-05	0.00192	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—AKAP13—cervical cancer	2.27e-05	0.0018	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH2—cervical cancer	2.12e-05	0.00168	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	2e-05	0.00159	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—WNT5A—cervical cancer	1.96e-05	0.00156	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.93e-05	0.00153	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—CA9—cervical cancer	1.55e-05	0.00123	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	1.53e-05	0.00121	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH2—cervical cancer	1.38e-05	0.00109	CbGpPWpGaD
Estramustine—ESR1—Gene Expression—NOTCH1—cervical cancer	1.31e-05	0.00104	CbGpPWpGaD
Estramustine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	1.28e-05	0.00102	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—HES1—cervical cancer	1.13e-05	0.000896	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TERT—cervical cancer	9.9e-06	0.000785	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—CA9—cervical cancer	9.54e-06	0.000756	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—FGFR3—cervical cancer	9.08e-06	0.00072	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—NOTCH1—cervical cancer	8.53e-06	0.000676	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—MTOR—cervical cancer	6.39e-06	0.000507	CbGpPWpGaD
Estramustine—ABCB1—Metabolism—MTHFR—cervical cancer	6.28e-06	0.000498	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CASP3—cervical cancer	5.88e-06	0.000466	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—CTNNB1—cervical cancer	5.67e-06	0.000449	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—STAT3—cervical cancer	4.94e-06	0.000392	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—EGFR—cervical cancer	4.49e-06	0.000356	CbGpPWpGaD
Estramustine—CYP3A4—Metabolism—MTHFR—cervical cancer	3.87e-06	0.000307	CbGpPWpGaD
Estramustine—ESR1—Signaling Pathways—TP53—cervical cancer	3.77e-06	0.000299	CbGpPWpGaD
